HIGHLIGHTS
- who: Uveal Melanoma et al. from the Department of Pharmacy, Linyi Central Hospital, Linyi, Shandong, China have published the research work: KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma, in the Journal: Disease Markers of 21/08/2022
- what: In this investigation an attempt was made to evaluate the prognostic usefulness of KDELR3 in UM particularly its connection with tumor-infiltrating lymphocytes (TILs). In this study, the mRNA expression of KDELR3 was shown to be significantly greater in the majority of different tumors, which suggested . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.